Results 161 to 170 of about 491,703 (337)

Mirtazapine for the Treatment of Depression and Nausea in Breast and Gynecological Oncology

, 2000
Diane Thompson
openalex   +1 more source

Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group [PDF]

, 2008
Noriyuki Katsumata, Yasuhiro Fujiwara, Toshiharu Kamura, Toru Nakanishi, M Hatae, Daisuke Aoki, K. Tanaka, Hiroshi Tsuda, Shoji Kamiura, Kazuhiro Takehara, Takao Sugiyama, J. Kigawa, Keiichi Fujiwara, Kazuhiko Ochiai, Ryoji Ishida, Mai Inagaki, K Noda   +16 more
openalex   +1 more source

Lipid metabolism and inflammation as key drivers in preterm birth: A comprehensive analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the alterations in lipid metabolites and circulating inflammatory factors associated with preterm birth, elucidate their interactions, and uncover the underlying pathophysiologic mechanisms. By identifying potential predictive biomarkers and informing the development of effective therapeutic interventions, this ...
Shu Xiao, ChaoChao Wei
wiley   +1 more source

A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: A gynecologic oncology group study [PDF]

, 2008
Joan L. Walker, Astrid Morrison, Paul DiSilvestro, Vivian E. von Gruenigen   +3 more
openalex   +1 more source

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group [PDF]

, 2008
Jalid Sehouli, Dirk Stengel, Guelten Oskay-Oezcelik, Alain G. Zeimet, Harald Sommer, Peter Klare, Martina Stauch, A. Paulenz, Oumar Camara, E. Keil, W. Lichtenegger   +10 more
openalex   +1 more source

Sexual harassment and gender discrimination in gynecologic oncology.

Gynecologic Oncology, 2020
M. Stasenko, C. Tarney, K. Seier, Y. Casablanca, C. Brown   +4 more
semanticscholar   +1 more source

Robotic versus open hysterectomy for very large uterus (more than 1000 g): A bicentric retrospective study of 150 patients

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare robotic (RAL) and open abdominal (OA) hysterectomy for very large uteri in terms of perioperative outcomes, complications, and costs. Methods Data from patients undergoing total hysterectomy between 2015 and 2021 for benign indications with a uterus weighing 1000 g or more according to the pathology report in two French ...
Thien‐Kim Do, Juan Pablo Estevez, Geoffroy Canlorbe, Clémentine Gonthier, Martin Koskas   +4 more
wiley   +1 more source

AKT inhibitors in gynecologic oncology: past, present and future. [PDF]

Front Oncol
Chen J, Yin R.
europepmc   +1 more source

Biweekly 72-Hour 9-Aminocamptothecin Infusion As Second-Line Therapy for Ovarian Carcinoma: Phase II Study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group

, 2003
Howard S. Höchster, Elizabeth R. Plimack, Carolyn D. Runowicz, James L. Speyer, Robert C. Wallach, Joan Sorich, John Mandeli, Scott Wadler, James R. Wright, Franco M. Muggia   +9 more
openalex   +1 more source

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

Gynecologic Oncology, 2016
A. Wright, Kari Bohlke, D. Armstrong, M. Bookman, W. Cliby, R. Coleman, D. Dizon, J. Kash, L. Meyer, K. Moore, A. Olawaiye, J. Oldham, R. Salani, Dee Sparacio, W. Tew, I. Vergote, M. Edelson   +16 more
semanticscholar   +1 more source